Skip to content

The effect of intravenous lidocaine infusion on postoperative delirium in patients undergoing elective brain tumor resection

The effect of intravenous lidocaine infusion on postoperative delirium in patients undergoing elective brain tumor resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117970
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumor

Interventions

Lidocaine group:10 minutes before anesthesia induction, lidocaine 1.5mg/kg was intravenously injected. During the operation, lidocaine was continuously pumped at a rate of 1.0mg/kg per hour. The pumpi
Control group:10 minutes before anesthesia induction, 1.5 mg/kg of normal saline was intravenously injected in equal volume. During the operation, 1.0 mg/kg/h of normal saline was continuously pumped.

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. ASA classification: grade II or III; 3. BMI: 18 - 30 kg/m^2; 4. Elective craniotomy for tumor resection under general anesthesia, without any prior radiotherapy or chemotherapy; 5. Simple mental state score (MMSE) normal: illiterate >= 17, primary school education >= 20, secondary school or higher education >= 24; Montreal Cognitive Assessment (MoCA) normal: >= 26 points. For those with an education level of <= 12 years (high school or below), the original score is corrected by adding 1 point.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Preoperative cognitive dysfunction or history of neurological disorders; 3. BMI >= 30 kg/m^2 or underweight (< 40 kg); 4. Obvious sinus tachycardia (heart rate < 50 beats/minute) or other severe cardiovascular diseases; 5. Hypoproteinemia; 6. Long-term use of psychotropic drugs, alcohol abuse; 7. Severe liver and kidney dysfunction; 8. History of surgery in the last 3 months; 9. Unable to complete the scale of this study; 10. Allergic to the drugs involved in this study; 11. Already participated in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Postoperative delirium;

Secondary

MeasureTime frame
Mini Mental State Scale score;Numerical rating scale score , NRS;Cognitive function status 30 days after operation;Hospital anxiety depression anxiety subscale score;Neutrophil to lymphocyte ratio;

Countries

China

Contacts

Public ContactXiuxia Chen

The Affiliated Hospital of Xuzhou Medical University

cxxlxy@sina.com+86 180 5226 8332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026